Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol + ketorolac + Apotel versus propofol + fentanyl for pediatric dental IV sedation
IRCT20090506001882N11Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Feb 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of propofol, ketorolac, acetaminophen, fentanyl, midazolam and 1 more in anxiety disorder (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Success of dental treatment according to Houpt Scale. Started Feb 2023; status: completed.
02
Drugs
propofolketorolacacetaminophenfentanylmidazolam
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on IRCT20090506001882N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090506001882N11.